Top Markets
#1 DogBull DogBull +55.75%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +28.67%
#3 DigiByte DigiByte +18.56%
#4 OriginTrail OriginTrail +16.95%
#5 Ethena Staked ENA Ethena Staked ENA +15.58%
#6 Ether.fi Ether.fi +11.05%
#7 Siren Siren +10.95%
#8 MarsCoin MarsCoin +10.44%
#9 龙虾 (Lobster) 龙虾 (Lobster) +9.81%
#10 Purr Purr +9.26%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Shine-On BioMedical Co.,Ltd. Shine-On BioMedical Co.,Ltd.

Shine-On BioMedical Co.,Ltd.

6926
Rank in Stocks #21821
Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and... Shine-On BioMedical Co.,Ltd. is dedicated to the research, development, and manufacturing of pharmaceutical products aimed at combating cancer. The company's innovative pipeline features a range of antibody-based oncology therapies. These include exosome anti-cancer drugs like SOB101 and SOB102, as well as SOB201, an engineered multi-target exosome. Additionally, their portfolio encompasses specialized antibody treatments such as SOA101, a dual immune checkpoint T cell adapter, and SOA201, a trispecific adapter immune cell antibody. This Taiwanese firm, founded in 2021, is based in Taichung.
Share Price
$2.00
Last synced: 2026-08-20
Market Cap
$99.77M
Change (1 day)
-0.47%
Change (1 year)
-15.35%
Country
TW
Trade Shine-On BioMedical Co.,Ltd. (6926)

Category

Healthcare
Revenue for Shine-On BioMedical Co.,Ltd. (6926)
Revenue in Aug 2026 TTM: 0
According to Shine-On BioMedical Co.,Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Shine-On BioMedical Co.,Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH